Iam trying to work on a fas extension file with using 'Biostrings' package. I have attempted a multiple different ways, exhausted google searches without much success on different webs/blogs/video tutorials.
I probably found an answer. Not quite sure if I can answer my own question. First, both comments by @Maurits and @Poshi were right. I appreciate them again. It's probably a longer version of what they wisely mentioned above, but my thought process is below. This is for other beginners who might fall into same misunderstanding that I went through... to save their time and energy.
First, the fas (or fasta, fa) files are essentially the same, if the file creator did not intend to fool the user by putting a different extension on purpose. One way to know whether it truly is based on the same format is, just by opening them in any ASCII text editor or equivalent environment and browse the first few lines. However, beware if the file size is huge, it will consume your RAM and make your computer uncomfortable.
Second, I checked whether the file truly contains the definition line as well as the sequence. I know it's a blunt way (and may not be totally accurate), but even before I went to ASCII level, I opened it on R with below:
Third, understand the fas (or fasta) can store all sequence in one line. It's basically a complex form of a list, and your sequence can be stored in different ways, but contiguous bases usually need not to be stored fragmented. So my sequence was all in one line!
I've been trying to install DESeq2 for differential expression analysis. Unfortunately, installation keeps failing because the dependencies can not be installed. The culprit is the XVector package, that is required for one of DESeq2's dependencies. This is the error:
Due to this zlib.h file that is not found, the installation fails. I'm working in rstudio hosted from a docker container based on the rocker/rstudio:4.0.5 (newer versions like 4.1.1 throw the same error). Installing zlib by running sudo apt-get install zlib1g in the docker container does not solve the problem, as zlib1g is already installed with the newest version.
If you are extending a rocker/rstudio image you should install the development version of some libraries (only they contain the header files which are needed to build the R-packages) and two additional libraries:
Thanks for your answer, this indeed solves my problem. Initially when I tried your solution I ran into several errors relating to packages that are not available. I learned that apt-get update needs to be run in the rocker/rstudio based container to find the packages. Next I could run apt-get install zlib1g-dev to solve the problem that occurred with XVector and apt-get install libxml2-dev to deal with another error that would otherwise occur, for reference:
Using R 4.1.2 (from the rocker/rstudio:4.1.2 docker image) results in the same problem as the other version. I tried using the bioconductor image (bioconductor/bioconductor_docker:latest) and this works without issues. I noticed that this docker container uses 4.3GB of disk space, while the previous containers end up using about 2.3GB. However, that is fine for me at the moment.
@swaiba - installing Biostrings will automatically identifiy and update all needed packages - this is not something you need to worry about directly. The root cause of your problem that prevents you to install Biostrings is that you are missing some software provided by the Linux OS, i.e. zlib.h.
You can solve the problem by running yum install zlib-devel on a RedHat Enterprise Linux based system or by running apt-get install zlib1g-dev on an Debian/Ubuntu based system. Once you installed this, the installation of Biostrings should be successful.
You also could use pak::pkg_install("Biostrings") which will install Biostrings as well - it will also tell you if any operating system dependencies (e.g. zlib.h) are missing - if run with admin privilegs, pak will automatically install those operating system dependencies for you.
This topic was automatically closed 42 days after the last reply. New replies are no longer allowed.
If you have a query related to it or one of the replies, start a new topic and refer back with a link.
The provided amounts of reagent and vector are optimized for high-titer lentivirus production in either a 10-cm dish or 96-well plate. Transfections can be carried out entirely in the presence of serum. Use of tetracycline-free FBS is critical for achieving high titers with this technology.
Lenti-X Packaging Single Shots (Ecotropic) provide a one-step production method to generate high-titer lentivirus. Each tube of Lenti-X Packaging Single Shots (Ecotropic) contains premeasured, lyophilized Xfect Transfection Reagent and an optimized formulation of Lenti-X lentiviral packaging plasmids. High-titer ecotropic lentivirus is produced by adding the lentiviral vector of choice in sterile water to the tube, reconstituting, and then using the mixture to transfect 293T cells (e.g., Lenti-X 293T Cell Line, Cat. # 632180) in a 10-cm dish.
Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.
Lenti-X Packaging Single Shots (Integrase Deficient) provide a one-step production method to generate high-titer lentivirus. Each tube of Lenti-X Packaging Single Shots (Integrase Deficient) contains pre-measured, lyophilized Xfect Transfection Reagent and an optimized formulation of Lenti-X lentiviral packaging plasmids. High-titer, integrase-deficient lentivirus is produced by adding the lentiviral vector of choice in sterile water to the tube, reconstituting, and then using the mixture to transfect 293T cells (e.g., Lenti-X 293T Cell Line, Cat. # 632180) in a 10-cm dish.
Lenti-X Packaging Single Shots (VSV-G) provide an extremely simple and consistent one-step method for producing high-titer lentivirus. No additional transfection reagent is needed because Lenti-X Packaging Single Shots (VSV-G) consist of pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of VSV-G pseudotyped Lenti-X lentiviral packaging plasmids. High-titer virus is produced by simply reconstituting this mixture with your lentiviral vector of choice in sterile water and adding it to 293T cells, e.g., Lenti-X 293T Cells (Cat. # 632180), in a 10 cm dish.
Consistent, high-efficiency transfections lead to high titers. A lentiviral vector containing the ZsGreen1 gene was packaged according to the Lenti-X single shots protocol in four independent experiments. Briefly, 7 g of pLVX-ZsGreen1 plasmid was added to each of four Lenti-X single shots; the tubes were vortexed for 20 sec and incubated at room temperature for 10 min. Then, the mixture was added to cultured Lenti-X 293T cells that were approximately 80% confluent. 48 hours after transfection, the cells were imaged by fluorescence microscopy (Panel A, top) and light microscopy (Panel A, bottom). After images were taken, the supernatant was harvested and used infect HT1080 cells for titer determination (Panel B, IFU/ml).
High-titer virus was produced regardless of the lentiviral vector backbone with Lenti-X packaging single shots. A CMV ZsGreen1 expression cassette was cloned into several lentiviral vector backbones. These vectors were then packaged into lentivirus using the Lenti-X packaging single shots following the provided protocol. Briefly, 7 g of pLVX-ZsGreen1 plasmid was added to each of four Lenti-X single shots, and the tubes were vortexed for 20 sec and incubated at room temperature for 10 min. Then, the mixture was added to cultured Lenti-X 293T cells that were approximately 80% confluent. After 48 hours, titer was determined using several methods. To determine infectivity, the supernatant was harvested and used to infect HT1080 cells (Flow Cytometry). Harvested viral supernatants were also analyzed by RT-PCR to quantify viral genome copies (qRT-PCR, Lenti-X qRT-PCR Titration Kit), ELISA to measure p24 (p24 ELISA, Lenti-X p24 Rapid Titer Kit), and by a rapid lentiviral detection method (Lenti-X GoStix).
A comparison of fourth- and third-generation lentiviral packaging systems . Our Lenti-X Packaging single shots utilize a packaging system that consists of five separate components (Panel A), mixed in proprietary proportions for optimized packaging activity. The separation of the gag, pol, and env genes effectively reduces the incidence of RCL (Wu et al., 2000). High levels of expression of essential viral components are driven by the Tet-Off and Tat transactivators, which induce a cascade of expression that results in high titers of lentivirus. The pol gene is fused to vpr to ensure transport of the reverse transcriptase/integrase protein into the recombinant lentiviral particle. Not all vector elements are shown. Other 3rd generation lentiviral packaging systems (Panel B) generate lower titers, do not contain separate gag and pol sequences, and do not use a transactivation cascade mechanism.
3a8082e126